# Dutch Acute HCV in HIV Study (DAHHS)

> **NCT01912495** · PHASE2 · COMPLETED · sponsor: **Erasmus Medical Center** · enrollment: 65 (actual)

## Conditions studied

- Hepatitis C
- Human Immunodeficiency Virus

## Interventions

- **DRUG:** Boceprevir

## Key facts

- **NCT ID:** NCT01912495
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2015-08
- **Final completion:** 2016-01
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2016-04-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01912495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01912495, "Dutch Acute HCV in HIV Study (DAHHS)". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT01912495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*